changes in protein profiles in bortezomib applied multiple myeloma ...
changes in protein profiles in bortezomib applied multiple myeloma ...
changes in protein profiles in bortezomib applied multiple myeloma ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
REFERENCES<br />
Aebersold, R. and Mann, M. 2003. Mass spectrometry-based proteomics. Nature 422:<br />
198-207.<br />
Abbott, A. 1999. A post-genomic challenge: learn<strong>in</strong>g to read patterns of prote<strong>in</strong><br />
synthesis. Nature 402: 715-20.<br />
Adams, J. M. 2003. Ways of dy<strong>in</strong>g: <strong>multiple</strong> pathways to apoptosis. Genes &<br />
Development 17: 2481–2495.<br />
Adams, J. 2003. The proteasome: structure, function, and role <strong>in</strong> the cell. Cancer<br />
Treatment Reviews 29(suppl 1): 3-9.<br />
Adams, J. and Kauffman, M. 2004. Development of the proteasome <strong>in</strong>hibitor Velcade<br />
(Bortezomib). Cancer Investigation 22(2): 304-11.<br />
Alberts, B., Johnson, A., Lewis, J., Raff, M., Roberts, K. and Walter, P. 2008.<br />
Molecular Biology of the Cell, 5th edition, New York, Garland Science.<br />
ACS, American Cancer Society. http :// www.cancer.org / acs / groups / cid / documents<br />
/ webcontent / 003121-pdf.pdf (accessed 2011).<br />
Alexanian, R., Barlogie, B. and Dixon, D. 1990. Renal failure <strong>in</strong> <strong>multiple</strong> <strong>myeloma</strong>.<br />
Pathogenesis and prognostic implications. Archives of Internal Medic<strong>in</strong>e 150:<br />
1693–1695.<br />
Anand, P., Kunnumakkara, A. B., Sundaram, C., Harikumar, K. B., Tharakan, S. T.,<br />
Lai, O. S., Sung, B. and Aggarwal, B. B. 2008. Cancer is a preventable disease<br />
that requires major lifestyle <strong>changes</strong>. Pharmaceutical Research (9): 2097-116.<br />
Anderson, K. C. 2003. Multiple Myeloma: How Far Have We Come? Mayo Cl<strong>in</strong>ic<br />
Proceed<strong>in</strong>gs 78: 15-17.<br />
Anderson, K. C. 2004. The cl<strong>in</strong>ical potential of proteasome <strong>in</strong>hibition. European Journal<br />
of Cancer Supplements 2(6): 3–6.<br />
Anderson, L. and Seilhamer, J. 1997. A comparison of selected mRNA and prote<strong>in</strong><br />
abundances <strong>in</strong> human liver. Electrophoresis 18: 533-7.<br />
Avet-Loiseau, H., Facon, T., Grosbois, B., et al. 2002. Oncogenesis of <strong>multiple</strong><br />
<strong>myeloma</strong>: 14q32 and 13q chromosomal abnormalities are not randomly<br />
89